ICUI up +14.19% percent Today $ICUI High is at 87.50 and

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 12:04 PM

ICUI up +14.19% percent Today $ICUI High is at 87.50 and the Low 80.15 with current volume of 516,922.

Recent News posted below.

Icu Medical ICUI other info.
http://investorshangout.com/ICU-Medical-Inc-ICUI-54414/

ICUI Icu Medical Recent Headline News

Eagle Pharmaceuticals (EGRX) Jumps: Stock Gains 8.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 17 mins ago
Eagle Pharmaceuticals (EGRX) was a big mover last session, with shares rising over 8% on the day.
ICUI: 82.12 (+10.31), ABAX: 53.31 (+0.37), GWPH: 74.79 (+0.84), EGRX: 13.51 (+0.01)

Upgrade Alert for ICU Medical (ICUI)
Comtex SmarTrend(R) - Tue Nov 11, 6:59AM CST
ICU Medical (NASDAQ:ICUI) was upgraded from Neutral to Buy at Roth Capital today. The stock closed yesterday at $71.81 on volume of 194,000 shares, above average daily volume of 126,000. ICU Medical share prices have moved between a 52-week high of $85.00 and a 52-week low of $35.58 and closed yesterday at 102% above that low price at $71.81 per share. The 200-day and 50-day moving averages have moved 0.16% higher and 0.83% higher over the past week, respectively.
ICUI: 82.12 (+10.31)

ICU Medical posts 3Q profit
Automated Insights - Tue Nov 11, 4:11AM CST
SAN CLEMENTE, Calif. (AP) _ ICU Medical Inc. (ICUI) on Tuesday reported profit of $6.4 million in its third quarter.
ICUI: 82.12 (+10.31)

ICU Medical's (ICUI) CEO Vivek Jain on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 6:51PM CST

ICUI: 82.12 (+10.31)

ICU Medical beats by $0.18, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:32PM CST

ICUI: 82.12 (+10.31)

ICU Medical (ICUI) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST

ICUI: 82.12 (+10.31)

ICU Medical, Inc. Announces Third Quarter 2014 Results
GlobeNewswire - Mon Nov 10, 3:11PM CST
ICU Medical, Inc., (Nasdaq:ICUI) ("ICU Medical"

, a leader in innovative medical devices used in vascular therapy, oncology and critical care applications, today announced financial results for the third quarter and nine months ended September 30, 2014.
ICUI: 82.12 (+10.31)

Walgreens Hits the Rock with Court's Ruling on CFO Lawsuit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 2:30PM CST
The controversy surrounding an inflated fiscal 2016 earnings forecast continues for leading drugstore chain Walgreen Co. (WAG).
BSX: 13.46 (+0.01), ICUI: 82.12 (+10.31), ABAX: 53.31 (+0.37), WAG: 67.54 (-0.24)

Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:35PM CST

HK: 2.85 (-0.40), WWD: 48.34 (-3.47), LLNW: 2.67 (+0.17), FXEN: 2.71 (-0.14), RMTI: 11.15 (+0.25), CZR: 11.28 (-0.26), EGY: 6.73 (-0.26), ICUI: 82.12 (+10.31), ICEL: 7.60 (-0.10), SAAS: 9.15 (+0.18), DMD: 5.72 (-1.41), NPSP: 29.36 (+2.45), SCLN: 8.20 (+0.10), ATHX: 1.52 (-0.02), CMLS: 3.05 (-0.24), TC: 2.16 (+0.20), ATW: 36.14 (-1.62), CLUB: 6.06 (-0.71), RAX: 42.24 (+4.92), PTLA: 27.50 (-0.15), IPAR: 29.29 (+0.07), ATLS: 37.06 (+0.19), AMBC: 24.39 (+1.02), CUI: 8.52 (+0.10), PDLI: 8.11 (+0.18), OMER: 18.59 (+1.10), PRAA: 61.68 (-2.17), CARA: 8.57 (-0.18), HALO: 8.84 (-0.48), MODN: 10.65 (+0.55), CALL: 8.69 (-1.80), ASEI: 48.79 (-7.30), HGR: 20.93 (+0.34), ERII: 4.44 (-0.54)

BioScrip (BIOS) Q3 Loss Wider than Expected, Revenues Top - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:10PM CST
BioScrip, Inc. (BIOS) recently declared its third-quarter 2014 results.
BSX: 13.46 (+0.01), ICUI: 82.12 (+10.31), ABAX: 53.31 (+0.37), BIOS: 5.68 (+0.09)

Omnicell Earnings Hit by High Tax, User Addition Aids Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:27AM CST
On Nov 7, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.46 (+0.01), ICUI: 82.12 (+10.31), ABAX: 53.31 (+0.37), OMCL: 31.97 (-0.52)

Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 82.12 (+10.31), ABAX: 53.31 (+0.37), GWPH: 74.79 (+0.84), HSP: 56.70 (+0.72)

Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:46AM CST
Sophiris Bio (SPHS) was a big mover last session, as the company saw its shares surge 25% on the day.
ICUI: 82.12 (+10.31), ABAX: 53.31 (+0.37), GWPH: 74.79 (+0.84), SPHS: 2.70 (-0.05)

Rockwell Medical (RMTI) Worth Watching: Stock Surges 21.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:25AM CST
Rockwell Medical (RMTI) was a big mover last session, as the company saw its shares surge over 21% on the day.
ICUI: 82.12 (+10.31), ABAX: 53.31 (+0.37), GWPH: 74.79 (+0.84), RMTI: 11.15 (+0.25)

CVS Health Beats Q3 Earnings, Revenues; Narrows Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 1:00PM CST
CVS Health Corporation (CVS) ??? formerly known as CVS Caremark ??? reported third-quarter 2014 adjusted earnings per share (EPS) of $1.15.
BSX: 13.46 (+0.01), ICUI: 82.12 (+10.31), ABAX: 53.31 (+0.37), CVS: 89.88 (+0.69)

Haemonetics Q2 Earnings Beat Estimates but Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:20PM CST
Haemonetics Corporation (HAE) reported adjusted earnings of 47 cents per share in the second quarter of fiscal 2015.
BSX: 13.46 (+0.01), ICUI: 82.12 (+10.31), ABAX: 53.31 (+0.37), HAE: 36.98 (+0.32)

14.1% Return Seen to Date on SmarTrend ICU Medical Call (ICUI)
Comtex SmarTrend(R) - Tue Nov 04, 11:13AM CST
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 3 months, ICU Medical has returned 14.13% as of today's recent price of $70.99.
ICUI: 82.12 (+10.31)

Cardiovascular Systems (CSII) Jumps: Stock Rises 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:46AM CST
Cardiovascular Systems (CSII) was a big mover last session, with shares rising over 6% on the day.
ICUI: 82.12 (+10.31), CSII: 29.76 (-0.26), ABAX: 53.31 (+0.37), GWPH: 74.79 (+0.84)

Strength Seen in AtriCure (ATRC): Stock Gains 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:25AM CST
AtriCure (ATRC) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 82.12 (+10.31), ABAX: 53.31 (+0.37), GWPH: 74.79 (+0.84), ATRC: 17.72 (+0.03)

ICU Medical Inc. (ICUI) Stock Research Links

ICUI Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...